Insights

Intellectual Property Intellectual Property

Type (0)

Results

All Insights

Osler Update March 15, 2021

Making sense of the battle for the CRISPR-Cas9 patent rights

There has been an ongoing legal battle for years over the intellectual property of the CRISPR-Cas9 technology. This Update makes sense of the battle...

Read more
Osler Update February 24, 2021

Canadian courts are interpreting supplementary pharmaceutical patent protection more broadly than their EU counterparts

In the first two Canadian Federal Court decisions to interpret the scope of CSPs, the Court ruled in favour of broad CSP protection where similar...

Read more
Osler Update February 18, 2021

Ontario Superior Court denies certification of Cambridge Analytica class action

On February 16, 2021, the Ontario Superior Court of Justice dismissed a motion for class certification in Simpson v. Facebook, Inc., a putative...

Read more
Osler Update January 26, 2021

Choueifaty patent application found to possess patentable subject-matter

The Commissioner of Patents' recent finding provides insight on the application of CIPO’s practice guidance, which is intended to comply with the...

Read more
Osler Update January 19, 2021

Making the best of a bad year: Winning IP cases in 2020

May Cheng and Sydney Young highlight their list of the key decisions in Canada in 2020 for each of the three main areas of IP law.

Read more
Osler Update December 8, 2020

2020: A year of clarity for Canadian life sciences and software patents

Two industries in which patents play an undeniable strategic role are life sciences and software. Canada has historically been a strategic...

Read more
Osler Update November 10, 2020

Canadian patent office issues guidance on computer-implemented and medical inventions following Choueifaty decision

The Canadian Intellectual Property Office (CIPO) has issued new guidance explaining how CIPO intends to apply the decision in Yves Choueifaty v...

Read more
Osler Update September 11, 2020

Federal Court invalidates tadalafil dosage patent finding dose selection to be routine

The Federal Court has issued its decision in Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816, invalidating Eli Lilly’s patent,...

Read more
Osler Update August 27, 2020

Federal Court clarifies Canadian approach to subject-matter eligibility for computer patents

In a recent decision, the Federal Court has rejected the Commissioner of Patents' “problem-solution” approach to claim construction when...

Read more
Osler Update July 2, 2020

United Kingdom’s highest court provides guidance on how to disclose inventions over large classes of products

In a recent landmark case, the United Kingdom’s highest court held that patents claiming a wide range of products must disclose how to make...

Read more